GTHCX Mutual Fund

NAV$17.96

TER1.82%

Holdings81

See how much of GTHCX you already own

Just $25 once·$99/mo·Download sample

X-ray my portfolio free

GTHCX Mutual Fund

NAV$17.96

Invesco Health Care Fund Class C

TER1.82%

Holdings81

See how much of GTHCX you already own

Just $25 once·$99/mo·Download sample

X-ray my portfolio free

Overview Performance Chart Dividends Top Holdings All Holdings Sectors Geography Similar Compare Overlap

Showing top 50 of 82 holdings · as of Aug 31, 2026

GTHCX holdings, by weight
#	Ticker	Name	Weight	Cumulative	Shares	Mkt value	Sector	Industry
1	LLY	Eli Lilly & Co.Health Care · Pharmaceuticals	10.38%	10.4%	111,322	$128.77M	Health Care	Pharmaceuticals
2	JNJ	Johnson & Johnson -Health Care · Pharmaceuticals	6.82%	17.2%	318,485	$84.67M	Health Care	Pharmaceuticals
Sector and industry · Pro
3	UNH	Unitedhealth Group Inc	5.28%	22.5%	168,361	$65.56M
4	MRK	Merck & Company Inc	5.07%	27.6%	425,626	$62.89M
5	ABBV	AbbVie Inc.	4.00%	31.6%	193,684	$49.66M
6	—	Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)	3.51%	35.1%	42,230	$43.57M
7	GILD	Gilead Sciences	3.31%	38.4%	280,656	$41.07M
8	—	Nvaesrtex Pharmaceuticals Inc	2.40%	40.8%	54,714	$29.79M
9	WELL	Welltower, Inc.	2.29%	43.1%	120,441	$28.45M
10	AMGN	Amgen Inc.	2.20%	45.3%	63,470	$27.28M
11	CVS	Cvs Health Corp.	2.20%	47.5%	291,313	$27.36M
12	TMO	Thermo Fisherscientific Inc.	2.18%	49.6%	43,909	$27.10M
13	RPRX	Royalty Pharma Plc Class A Ordinary Share	2.18%	51.8%	440,990	$27.08M
14	CAH	Cardinal Health Inc.	2.08%	53.9%	110,152	$25.84M
15	GH	Guardant Health, Inc	1.95%	55.9%	152,178	$24.20M
16	BTSG	Brightspring Health	1.92%	57.8%	407,041	$23.77M
17	EW	Edwards Lifesciences Corp	1.60%	59.4%	219,094	$19.88M
18	WAT	Waters Corp.	1.51%	60.9%	45,153	$18.72M
19	IQV	Iqvia Holdings Inc	1.43%	62.3%	67,768	$17.70M
20	AXSM	Axsome Therapeutics Inc	1.40%	63.7%	87,700	$17.41M
21	Debt	Invesco Short-term Investments Trust, Treasury Portfolio, Institutional Class 0.0102% 2021-01-07	1.40%	65.1%	17,398,822	$17.40M
22	NTRA	Natera Inc	1.37%	66.5%	52,670	$16.96M
23	BBIO	Bridgebio Pharma Inc_None_0	1.33%	67.8%	216,227	$16.56M
24	HALO	Halozyme Therapeutics Inc	1.33%	69.1%	155,098	$16.52M
25	CRL	Charles River Laboratories International Inc	1.28%	70.4%	55,054	$15.87M
26	PTGX	Protagonist Therapeutics Inc	1.24%	71.7%	103,952	$15.36M
27	RVMD	Revolution Medicines Inc	1.16%	72.8%	69,866	$14.36M
28	SDZ	Sandoz Group Ag	1.15%	74.0%	169,209	$14.21M
29	ASND	Ascendis Pharma A/S	1.15%	75.1%	54,101	$14.23M
30	LGND	Ligand Pharmaceuticals, Inc.	1.13%	76.3%	49,408	$14.04M
31	DGX	Quest Diagnostics Inc	0.99%	77.2%	50,956	$12.24M
32	ISRG	Intuitive Surgical Inc.	0.93%	78.2%	30,687	$11.56M
33	MDGL	Madrigal Pharmaceuticals Inc	0.92%	79.1%	21,162	$11.43M
34	MTD	Mettler-Toledo International Inc.	0.89%	80.0%	7,844	$11.02M
35	GALD	Galderma	0.83%	80.8%	49,726	$10.31M
36	WST	West Pharmaceutical Services Inc	0.77%	81.6%	27,934	$9.53M
37	TWST	Twist Bioscience Corp.	0.75%	82.3%	67,195	$9.34M
38	LH	Labcorp Holdings Inc	0.74%	83.1%	27,780	$9.24M
39	MEDP	Medpace Holdings Inc	0.74%	83.8%	15,549	$9.24M
40	AGPXX	Invesco Government & Agency Portfolio, Institutional Class	0.73%	84.5%	9,016,356	$9.02M
41	LONN	Lonza Group AG Ordinary Shares	0.70%	85.2%	12,228	$8.71M
42	THC	Tenet Healthcare Corp	0.68%	85.9%	31,528	$8.38M
43	CYTK	Cytokinetics Inc	0.62%	86.5%	107,839	$7.65M
44	—	Steris Plc Ordinary Shares	0.62%	87.2%	33,121	$7.71M
45	KRYS	Krystal Biotech Inc	0.59%	87.8%	20,337	$7.31M
46	—	Teva Pharmaceutical Industries Limited (Adr)	0.58%	88.3%	200,906	$7.24M
47	GMED	Globus Medical, Inc. (Class A)	0.57%	88.9%	87,598	$7.13M
48	ARWR	Arrowhead Pharmaceuticals Inc	0.54%	89.4%	81,814	$6.74M
49	—	Emcompass Health Corp	0.52%	90.0%	53,477	$6.43M
50	GKOS	Glaukos Corp.	0.52%	90.5%	35,731	$6.42M
More holdings · Pro

Not reported for this fund: share changes.

FundXLS Pro

See the other 32 holdings of GTHCX

X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.

Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

GTHCX Mutual Fund All Holdings

GTHCX holdings total 81 positions. The top 10 holdings account for 45.3% of the fund, led by Eli Lilly & Co. at 10.4%, Johnson & Johnson - Common at 6.8%, Unitedhealth Group Incorporated at 5.3%.

GTHCX portfolio concentration is moderate, with the top 10 representing 45.3% of total assets. The largest sector exposure is Health Care at 88.6%.

GTHCX sectors provide a detailed breakdown. GTHCX overlap shows how holdings compare to other funds in your portfolio.